Healthcare investment firm Concord Health Partners revealed on Thursday that it has successfully led an investment in VitalTech Holdings Inc.
Stanley Black & Decker's corporate venture arm co-invested and simultaneously entered into a commercial agreement with VitalTech to distribute products and services.
VitalTech is a remote patient monitoring and digital health company that has developed medical grade biosensors integrated into a suite of wireless mobile devices and software services. Its digital health platform is designed to simplify workflows and support connected care through remote patient monitoring.
The investment in VitalTech reflects Concord's focus on reducing healthcare delivery costs and improving quality of care through innovative technologies and solutions.
Halma acquires Rovers Medical Devices
boston Scientific granted FDA approval for AGENT Drug-Coated Balloon
Enable Injections names new chief operating officer
BridgeBio Pharma and Kyowa Kirin partner on infigratinib for skeletal dysplasias in Japan
Redwood Scientific signs agreement with Jeeva Clinical Trials
Tissue Regenix ships first allograft products in the EU post-HPRA approval
Kromek secures GBP1.3m grant for AI-powered radiation sensor project